Press release
Tinea Versicolor Treatment Market Projected to Grow Radiantly By 2023 | Industry Growth Influencer - Astellas Pharma , Inc. , Bayer AG , Enzon Pharmaceuticals, Inc. , Galderma S.A., Gilead, Novartis AG , Pfizer Inc.
Tinea Versicolor Treatment Market -Overview
Tinea Versicolor is one of the common types of skin infection. It also called as pityriasis versicolor. In this condition, small and discolored patches of skin occur, mostly affecting the shoulders and trunk.
Increasing prevalence of tinea versicolor, increasing awareness of the disease, rising healthcare expenditure, advanced diagnosis and treatment options, and approval of new antifungal medicines are leading the growth of global tinea versicolor treatment market.
Global tinea versicolor treatment market is expected to grow at the CAGR of ~7.1% during the forecast period and is estimated to reach USD 197.9 million by 2023.
Tinea Versicolor Treatment Market -Market Segments
Global tinea versicolor treatment market has been segmented on the basis of diagnosis which comprise physical exam, imaging tests, and others. Imaging test is sub-segmented into wood lamp (black light) examination, microscopy using potassium hydroxide (KOH), fungal culture, skin biopsy, and others. Skin biopsy is sub-segmented into shave biopsy, punch biopsy, excisional biopsy, and others.
On the basis of treatments, the market has been segmented into antifungal shampoos, antifungal creams, drugs, and others. Antifungal shampoos are sub-segmented into selenium sulfide (selsun) 2.5 percent shampoo, ciclopirox (loprox, penlac) shampoo, ketoconazole (ketoconazole, nizoral, others) shampoo, and others. Antifungal creams are sub-segmented into Selenium sulfide (Selsun) 2.5 percent lotion, Ciclopirox (Loprox, Penlac) cream or gel, Ketoconazole (Ketoconazole, Nizoral, others) cream or gel, and others. Drugs are further sub-segmented into fluconazole (diflucan) tablets or oral solution, and others.
Get PDF with Technological Advancement @ https://www.marketresearchfuture.com/sample_request/3878
Tinea Versicolor Treatment Market -Key developments
Major players in the market are engaged in the development of new products to capture the market globally. Thus, key market players are investing more in research and development activity, in order to lead the global market. In this regards, market players undertake various strategic approaches.
In March 2016, Novartis cancer drug gets FDA's principal 'biosimilar' affirmation. Federal regulators have permitted the first “biosimilar” drug to be sold in the U.S. under a program intended to branch a new market of lower-cost substitutes to some of the most expensive treatments in healthcare.
In May 2016, Novartis studies new sales model for tentative cancer therapy. Novartis strategies to use a medical device-like sales model to market its CAR T-cell technology if the new cancer treatment receives FDA approval.
Tinea Versicolor Treatment Market -Regional Analysis
Considering the global scenario of the market, America is the top contributor in this market. The Americas mainly include North America and South America. Due to large amount of money invested in research, clinical trials, and new product development, US is the dominating country in this region.
Europe is the second largest market for tinea versicolor treatment. Germany is dominating this market while UK is the fastest growing tinea versicolor treatment market. Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly improving healthcare facilities, increasing awareness of disease, and rising healthcare expenditure. Middle East & Africa is expected to have limited growth.
Obtain Report Details with Technological Advancement @ https://www.marketresearchfuture.com/reports/tinea-versicolor-treatment-market-3878
Tinea Versicolor Treatment Market -Key Players
Astellas Pharma US, Inc. (Japan)
Bayer AG (German)
Enzon Pharmaceuticals, Inc. (US)
Galderma S.A. (Switzerland)
Gilead (US)
Novartis AG (Switzerland)
Pfizer Inc. (US)
Taro Pharmaceutical Industries Ltd. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Valeant (Canada)
Major Points form TOC for Tinea Versicolor Treatment Market Research Report – Forecast to 2023
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Tinea Versicolor Treatment Market, By Type
Chapter 7. Global Tinea Versicolor Treatment Market, By Treatment
Chapter 8 Global Tinea Versicolor Treatment Market, By End User
Chapter 9. Global Tinea Versicolor Treatment Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 12. MRFR Conclusion
Chapter 13. Appendix
Get Excusive Discount @ https://www.marketresearchfuture.com/check-discount/3878
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tinea Versicolor Treatment Market Projected to Grow Radiantly By 2023 | Industry Growth Influencer - Astellas Pharma , Inc. , Bayer AG , Enzon Pharmaceuticals, Inc. , Galderma S.A., Gilead, Novartis AG , Pfizer Inc. here
News-ID: 1312719 • Views: …
More Releases from Market Research Future
Take-Out Fried Chicken Market to Reach USD 13.04 Billion by 2034 at 5.5% CAGR, D …
The global take-out fried chicken market is poised for significant growth over the next decade, with projections estimating the market value to surge from USD 8.05 billion in 2025 to an impressive USD 13.04 billion by 2034. According to Market Research Future Analysis, this growth will be driven by a robust compound annual growth rate (CAGR) of 5.5% during the forecast period. Several key factors contribute to this expanding market,…
Coconut Oil Market to Reach USD 8.56 Billion by 2032 at 5.58% CAGR, Driven by Fo …
The global coconut oil market is poised for significant growth, projected to reach a valuation of USD 8.56 billion by 2032, expanding at a robust compound annual growth rate (CAGR) of 5.58% from 2024 to 2032, according to recent analysis by Market Research Future. This upward trajectory is being driven by rising health consciousness among consumers worldwide and the expanding use of coconut oil across multiple industries such as personal…
Olive Oil Market to Reach 5.5 USD Billion by 2035 at 3.44% CAGR Driven by Rising …
The global olive oil market is poised for significant growth over the coming decade, with projections indicating it will reach a valuation of USD 5.5 billion by 2035. According to a recent Market Research Future analysis, the market was valued at USD 3.66 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 3.44% between 2025 and 2035. This growth trajectory is driven primarily…
Pet Food Market: Meeting Growing Demand through Innovation and Quality Nutrition …
Pet Food Market Outlook
The pet food market is witnessing significant growth fueled by rising pet ownership, increasing humanization of pets, and growing awareness of pet health and nutrition. Market Research Future provides insight into this dynamic industry, projecting substantial expansion driven by innovation, product diversification, and evolving consumer preferences.
Market Size and Growth
Valued at approximately USD 80 billion in 2023, the pet food market is expected to sustain a robust growth…
More Releases for Tinea
Foot & Ankle Injuries Fueling Tinea Pedis Market Growth: Pivotal Factor Influenc …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Tinea Pedis Treatment Market Size Growth Forecast: What to Expect by 2025?
In recent times, the tinea pedis treatment market has seen robust growth. The market is projected to increase from $1.36 billion in 2024 to $1.45 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%.…
Tinea Corporis Market New Product Development & Latest Trends
Tinea Corporis market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Tinea Corporis Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as…
Global Onychomycosis (Tinea Unguium) Drug Market
Onychomycosis (Tinea Unguium) Drug Market Forecast 2020-2026
The Global Onychomycosis (Tinea Unguium) Drug Market research report provides and in-depth analysis on industry- and economy-wide database for business management that could potentially offer development and profitability for players in this market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes…
Tinea Corporis Drugs Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Tinea Corporis Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Tinea Corporis Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Tinea Corporis Drugs with respect…
Tinea Pedis Treatment Market Dynamic Business Environment during 2017 - 2025
Global Tinea Pedis Treatment Market: Snapshot
Athlete's foot known medically as tinea pedis, is a common skin infection of the feet caused by various kinds of fungi. Signs and symptoms often include itching, scaling, cracking and redness. In rare cases, the skin may blister. Athlete's foot fungus may infect any part of the foot, but most often grows between the toes. Apart from these areas, the fungus might develop at the…
Tinea Pedis Treatment Market 2017- GSK, Exeltis USA, Valeant
Marketreports.biz, recently published a detailed market research study focused on the "Tinea Pedis Treatment Market" across the global, regional and country level. The report provides 360° analysis of "Tinea Pedis Treatment Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Tinea Pedis Treatment industry, and estimates the future trend of Tinea…
